Enhanced delivery of doxorubicin into the brain via a peptide-vector-mediated strategy: Saturation kinetics and specificity

Journal of Pharmacology and Experimental Therapeutics

Volumn 296, Issue 1, 2001, Pages 124-131

  Rousselle, Christophe ^a   Smirnova, Maria ^a   Clair, Philippe ^b   Lefauconnier, Jeanne Marie ^a   Chavanieu, Alain ^c   Calas, Bernard ^c   Scherrmann, Jean Michel ^a   Temsamani, Jamal ^b  

^a HÔPITAL FERNAND WIDAL   (France)

^b Synt:em   (France)

^c UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; GLYCOPROTEIN P; POLYLYSINE; PROTAMINE; SYN B1; SYN B3; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ADSORPTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN PERFUSION; COVALENT BOND; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG UPTAKE; ENDOCYTOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSPORT KINETICS;

ALGORITHMS; AMINO ACID SEQUENCE; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; DOXORUBICIN; ENDOCYTOSIS; FUNCTIONAL LATERALITY; KINETICS; MALE; MICE; MICROCIRCULATION; MOLECULAR SEQUENCE DATA; PEPTIDES; PERFUSION; POLYLYSINE; STEREOISOMERISM;

EID: 0035196836     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Possible involvement of multidrug-resistanceassociated protein (MRP) gene expression in spontaneous drug resistance to vincristine, etoposide and adriamycin in human glioma cells
2. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model
3. Carrier-mediated transport of enkephalins and N-tyr-MIF-1 across blood-brain barrier
4. Insulin binding to microvascular endothelium of intact heart: A kinetic and morphometric analysis
5. Development of an in situ mouse brain perfusion model and its application to mdr1a P-glycoprotein-deficient mice
6. Trojan peptides: The penetratin system for intracellular delivery
7. Blood-brain barrier transcytosis of insulin in developing rabbits
8. Clinical studies with modulators of multidrug resistance
9. Receptor-mediated transcytosis of transferrin across the blood-brain barrier
10. Binding and internalization of insulin and insulin-like growth factors by isolated brain microvessels
11. Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles
12. Determination of disulphide bridges in PG-2, an antimicrobial peptide from porcine leukocytes
13. Brain drug delivery of small molecules using immunoliposomes
14. Improving drug delivery to intracerebral tumor and surrounding brain in a rodent model: A comparison of osmotic versus bradykinin modification of the blood-brain and/or blood-tumor barriers
15. Adsorptive-mediated endocytosis of cationized albumin and a beta-endorphin-cationized albumin chimeric peptide by isolated brain capillaries. Model system of blood-brain barrier transport
16. Inhibitory effects of a cyclosporin derivative, SDZ PSC 833, on transport of doxorubicin and vinblastine via human P-glycoprotein
17. Change in membrane permeability induced by protegrin 1: Implication of disulphide bridges for pore formation
18. Kinetics of anthracycline efflux from multidrug resistance protein-expressing cancer cells compared with P·glyceprotein-expressing cancer cells
19. Charge-related alterations of the cerebral endothelium
20. In vivo and in vitro evidence for ATP-dependency of P-glycoprotein-mediated efflux of doxorubicin at the blood-brain barrier
21. Indirect evidence that drug brain targeting using polysorbate 80-coated polybutylcyanoacrylate nanoparticles is related to toxicity
22. Non-invasive drug delivery to the human brain using endogenous blood-brain barrier transport systems
23. Human blood-brain barrier transferrin receptor
24. Transport of human recombinant brain-derived neurotrophic factor (BDNF) through the rat blood-brain barrier in vivo using vector-mediated peptide drug delivery
25. Transport of histone through the blood-brain barrier
26. New advances in the transport of doxorubicin through the blood-brain barrier by a peptide-vector mediated strategy
27. In vivo protein transduction: Delivery of a biologically active protein into the mouse
28. Transferrin as a targeting ligand for liposomes and anticancer drugs
29. Brain perfusion systems for studies of drug uptake and metabolism in the central nervous system
30. Permeability and mechanism of albumin, cationized albumin, and glycosylated albumin transcellular transport across monolayers of cultured bovine brain capillary endothelial cells
31. Characterisation of specific receptors for atrial natriuretic factor on cultured bovine brain capillary endothelial cells
32. Structure-internalization relationship for adsorptive-mediated endocytosis of basic peptides at the blood-brain barrier
33. Brain drug delivery technologies: Novel approaches for transporting therapeutics
34. Absorptive-mediated endocytosis of a dynorphin-like analgesic peptide, E-2078, into the blood-brain barrier
35. Adsorptive-mediated endocytosis of an adrenocerticotropic hormone (ACTH) analogue, ebiratide, into the blood-brain barrier: Studies with monolayers of primary cultured bovine brain capillary endothelial cells
36. Drug delivery to the brain utilizing blood-brain barrier transport systems
37. Capillary depletion method for quantification of blood brain barrier transport of circulating peptides and plasma proteins
38. Increased accumulation of doxorubicin and doxorubicinol in cardiac tissue of mice lacking mdr1a P-glycoprotein
39. Ultracytochemical characterization of anionic sites in the wall of brain capillaries
40. Altering the blood-brain barrier in the rat by intracarotid infusion of polycations: A comparison between protamine, poly-L-lysine and poly-L-arginine